Tag Archives: PrEP

Almost one in ten HIV PrEP users report buying antibiotics for STI prevention, raising concerns over potential antibiotic resistance

An online community survey conducted in the UK shows that 9% of HIV PrEP users are buying antibiotics to prevent themselves from getting STIs. The survey results from 2019 were published in last month in the Sexually Transmitted Infections journal. Those buying antibiotics were more likely to have had at least five condomless sexual partners… Read More »

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

HPTN 084 study finds significantly lower adherence in women taking daily PrEP pills A second study of an injectable HIV drug used to prevent HIV has had its randomised phase stopped early after it became clear that giving women a two-monthly injection of a prevention drug resulted in nearly nine times fewer infections than giving… Read More »

Australian researchers present two possible ‘PrEP cascades’ that could be used to measure uptake

The most recent of a series of national gay men’s surveys in Australia shows that over one in seven (14.7%) of all the non-HIV positive respondents in the 2018 survey is taking PrEP. A smaller survey conducted in 2017, which focused on gay men’s opinions of biomedical prevention alone, found that one in five (20.5%) were… Read More »

Truvada Should Remain First Choice for PrEP, Experts Argue

Claims about the superiority of Descovy, the new pre-exposure prophylaxis (PrEP) option, are “overstated,” and Truvada remains a highly effective and safe choice for the vast majority of PrEP users, according to a commentary in the Annals of Internal Medicine.   Truvada, approved for HIV treatment in 2004 and for PrEP in 2012, contains tenofovir… Read More »

Hepatitis C screening among PrEP users could eliminate hepatitis C infections in gay men in the UK

Increasing the frequency of hepatitis C screening in gay and bisexual men taking pre-exposure prophylaxis (PrEP) in the United Kingdom has the potential to reduce new hepatitis C infections in the UK by 2030, especially if the proportion of men taking PrEP increases to 25%, researchers report in the journal EClinical Medicine. Background Hepatitis C… Read More »